During the past decade, Eclipse Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eclipse Clinical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Abbott Nutrition" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eclipse Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Eclipse Clinical Research" are "Type 2 Diabetes" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Hot Flashes" (2 trials), "Type 2 Diabetes Mellitus" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Eclipse Clinical Research" in a lesser frequency.

Most popular intervention types in "Eclipse Clinical Research" are "Drug" (17 trials), "Other" (3 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Dapagliflozin" (2 trials), "Diet" (2 trials), "Exercise" (2 trials) and "Obicetrapib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eclipse Clinical Research" are 18 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Eclipse Clinical Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Eclipse Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Eclipse Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".